The Technical Analyst
[]
Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.84% 113.53
/
| RATING 2022-04-15 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | |||
|---|---|---|---|
| 4/20 | 1/21 | 2/21 | |
| Revenue | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a |
| Ebit | n/a | n/a | |
| Asset | n/a | ||
| Debt | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
12.13 - 12.85 ( +/- 2.86%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | 113.53 (0.84% ) |
| Volume | 0.234 mill |
| Avg. Vol. | 0.279 mill |
| % of Avg. Vol | 83.95 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
Latest Press Releases
2021-05-05 07:30:00 - Press Release
Linden And Dw Healthcare Partners Complete Hydrafacial's Public Offering Via Spac Merger
Chicago and park city, utah, may 5, 2021 /prnewswire/ -- linden capital partners ("linden") and dw healthcare partners iv, lp ("dw healthcare partners"), both private equity firms focused exclusively on the healthcare sector, announced today the completion of the merger of edge systems, llc ("hydrafacial"), a category-creating beauty health company, with vesper healthcare acquisition corp. (nasdaq: vspr) ("vesper" or "vesper healthcare"). vesper is a special purpose acquisition company ("spac") led by former allergan ceo brent saunders.
2021-04-21 06:45:00 - Press Release
Hydrafacial Announces Record First Quarter Fiscal 2021 Preliminary Net Sales
Miami beach, fla. & long beach, calif.--(business wire)--the hydrafacial® company (“hydrafacial,” or the “company”), an experiential category-creating beauty health company, today announced preliminary net sales for the quarter ended march 31, 2021. the company has not yet completed the quarter-end review and expects to report full results for the first quarter of 2021 at a future date. the previously announced business combination with vesper healthcare acquisition corp. (“vesper healthcare”) (nasdaq: vspr) is expected to be completed in the first half of 2021. upon completion of the transaction, vesper healthcare expects to rebrand as the beauty health company, and list on the nasdaq capital market under the ticker symbol “skin”...
2021-02-22 06:45:00 - Press Release
Hydrafacial, A Beauty Health Company, Announces 2020 Preliminary Net Sales
Miami beach, fla. & long beach, calif.--(business wire)--the hydrafacial® company (“hydrafacial,” or the “company”), a category-creating beauty health company, today announced preliminary net sales for the fiscal year ended december 31, 2020. hydrafacial currently expects net sales for fiscal year 2020 to approximate $119 million. the company's previous expectation for net sales, provided on december 9, 2020, was approximately $115 million. the company has not yet completed the year-end audit a
2020-12-09 06:55:00 - Press Release
Hydrafacial, An Experiential Beauty Health Company, And Vesper Healthcare Announce Business Combination
Miami beach, fla. & long beach, calif.--(business wire)--the hydrafacial® company (“hydrafacial,” or the “company”), a category-creating beauty health company, and vesper healthcare acquisition corp. (nasdaq: vspr) (“vesper healthcare”), a special purpose acquisition company co-founded by brent saunders, former ceo of allergan, forest laboratories, and bausch + lomb, today announced that they have entered into a definitive merger agreement pursuant to which hydrafacial and vesper healthcare will combine, and after which hydrafacial will become a public company. upon completion of the transaction, the combined company expects to be listed on the nasdaq exchange. hydrafacial is owned by linden capital partners (“linden”) and dw healthcare partners iv, lp (“dwhp”) both of which are private equity firms focused exclusively on the healthcare industry...
Latest News
2021-05-05 07:30:00 - PRNewsWire
Linden and DW Healthcare Partners Complete HydraFacial's Public Offering via SPAC Merger
CHICAGO and PARK CITY, Utah, May 5, 2021 /PRNewswire/ -- Linden Capital Partners ("Linden") and DW Healthcare Partners IV, LP ("DW Healthcare Partners"), both private equity firms focused exclusively on the healthcare sector, announced today the completion of the merger of Edge Systems, LLC ("HydraFacial"), a category-creating beauty health company, with Vesper Healthcare Acquisition Corp. (NASDAQ: VSPR) ("Vesper" or "Vesper Healthcare"). Vesper is a special purpose acquisition company ("SPAC") led by former Allergan CEO Brent Saunders.
2021-04-22 05:15:49 - Seeking Alpha
HydraFacial: A Long-Term Play On Booming Demand For Enhanced Skincare
HydraFacial is going public via a special purpose acquisition company at an enterprise value of $1.1 billion.
2021-04-21 06:45:00 - Business Wire
HydraFacial Announces Record First Quarter Fiscal 2021 Preliminary Net Sales
MIAMI BEACH, Fla. & LONG BEACH, Calif.--(BUSINESS WIRE)--The HydraFacial® Company (“HydraFacial,” or the “Company”), an experiential category-creating beauty health company, today announced preliminary net sales for the quarter ended March 31, 2021. The Company has not yet completed the quarter-end review and expects to report full results for the first quarter of 2021 at a future date. The previously announced business combination with Vesper Healthcare Acquisition Corp. (“Vesper Healthcare”)
2021-02-22 06:45:00 - Business Wire
HydraFacial, a Beauty Health Company, Announces 2020 Preliminary Net Sales
MIAMI BEACH, Fla. & LONG BEACH, Calif.--(BUSINESS WIRE)--The HydraFacial® Company (“HydraFacial,” or the “Company”), a category-creating beauty health company, today announced preliminary net sales for the fiscal year ended December 31, 2020. HydraFacial currently expects net sales for fiscal year 2020 to approximate $119 million. The Company's previous expectation for net sales, provided on December 9, 2020, was approximately $115 million. The Company has not yet completed the year-end audit a
2021-01-08 11:44:30 - GuruFocus
A Closer Look at Seth Klarman's SPAC Holdings
2020-12-15 14:13:25 - Seeking Alpha
Vesper Healthcare Acquisition: Another SPAC To Own
Vesper Healthcare Acquisition agrees to acquire HydraFacial in a deal valued at up to $1.1 billion. The experiential beauty health company is looking to build a platform of services for medical spas to grow the TAM in the health and beauty sector.